Literature DB >> 27039166

Impact of renal function on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study.

Monica Verdoia1, Lucia Barbieri1, Alon Schaffer1, Giorgio Bellomo2, Paolo Marino3, Giuseppe De Luca4.   

Abstract

BACKGROUND: Mean platelet volume (MPV) has been proposed as a marker of platelet reactivity and cardiovascular disease. Chronic kidney disease (CKD) significantly favors the occurrence of cardiovascular events, by increasing the circulating levels of a wide spectrum of pro-oxidant and pro-thrombotic mediators. However, opposite alterations of platelet function, both enhanced aggregability and increased bleeding diathesis have been reported in these patients, with contrasting results on the effects of renal function on MPV and coronary artery disease, that were assessed in present study.
METHODS: In patients undergoing coronary angiography, MPV and renal function (serum creatinine and estimated Glomerular Filtration Rate, eGFR, by MDRD formula) were assessed at admission. Coronary artery disease (CAD) was defined as a stenosis >50% in at least 1 coronary vessel, while severe CAD as left main or trivessel disease.
RESULTS: Among 3712 patients, 1044 (28.1%) had chronic kidney disease. CKD was related with age, female gender, diabetes and glycemic control, history of myocardial infarction, cerebrovascular accidents, coronary artery bypass grafting and left ventricular dysfunction or arrhythmias as indication to angiography, therapy with angiotensin-receptor blockers, nitrates, diuretics and calcium-antagonists, but lower rate of smoking, lower fibrinogen levels, haemoglobin, total and HDL cholesterol (p<0.001, respectively). CKD patients displayed increased severity and complexity of CAD (p<0.001) and significantly larger platelet volume (p<0.001), with CKD resulting as independent predictor of MPV above the median (≥10.85fl; Adjusted OR[95%CI]=1.56[1.23,1.99], p=0.002). Moreover, in the 1044 patients with renal failure, higher platelet volume (above the median value; ≥10.85fl) was associated with age (p=0.05), haemoglobin levels and platelet count (p<0.001), but not to a higher prevalence or extent of coronary artery disease (CAD: adjusted OR[95%CI]=0.80[0.58-1.09], p=0.16; severe CAD, adjusted OR[95%CI]=1.07[0.81-1.41], p=0.65).
CONCLUSIONS: Higher values of MPV are observed among patients with chronic kidney disease, inversely relating to eGFR. However, larger platelet size does not contribute to explain the increased severity of coronary artery disease observed among these patients.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coronary angiography; Coronary artery disease; Platelet; Renal function; Size

Mesh:

Year:  2016        PMID: 27039166     DOI: 10.1016/j.thromres.2016.03.018

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Renal denervation for resistant hypertension: the wrong target?

Authors:  Shi-Sheng Zhou; Yiming Zhou
Journal:  Nat Rev Cardiol       Date:  2016-06-03       Impact factor: 32.419

2.  Hematological Parameters and Clinical Features in Patients with Advanced Chronic Kidney Disease.

Authors:  Ertugrul Erken; Cansu Ulgen; Feyza Nur Sarisik; Neziha Erken; Ozkan Gungor; Orcun Altunoren
Journal:  Yonago Acta Med       Date:  2020-10-10       Impact factor: 1.641

3.  The mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis.

Authors:  Jacek Staszewski; Aleksandra Pogoda; Kamila Data; Klaudia Walczak; Maciej Nowocień; Emilia Frankowska; Adam Stępień
Journal:  Clin Interv Aging       Date:  2019-02-27       Impact factor: 4.458

4.  Mean platelet volume is more important than age for defining reference intervals of platelet counts.

Authors:  Till Ittermann; Martin A Feig; Astrid Petersmann; Dörte Radke; Andreas Greinacher; Henry Völzke; Thomas Thiele
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

5.  Mapping eGFR loci to the renal transcriptome and phenome in the VA Million Veteran Program.

Authors:  Jacklyn N Hellwege; Digna R Velez Edwards; Ayush Giri; Chengxiang Qiu; Jihwan Park; Eric S Torstenson; Jacob M Keaton; O D Wilson; Cassianne Robinson-Cohen; Cecilia P Chung; Christianne L Roumie; Derek Klarin; Scott M Damrauer; Scott L DuVall; Edward Siew; Elvis A Akwo; Matthias Wuttke; Mathias Gorski; Man Li; Yong Li; J Michael Gaziano; Peter W F Wilson; Philip S Tsao; Christopher J O'Donnell; Csaba P Kovesdy; Cristian Pattaro; Anna Köttgen; Katalin Susztak; Todd L Edwards; Adriana M Hung
Journal:  Nat Commun       Date:  2019-08-26       Impact factor: 14.919

6.  Comparing Medical Comorbidities Between Opioid and Cocaine Users: A Data Mining Approach.

Authors:  Yong-Mi Kim
Journal:  Addict Health       Date:  2019-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.